Unraveling the Potential of ALK-Targeted Therapies in Non-Small Cell Lung Cancer: Comprehensive Insights and Future Directions

Unraveling the Potential of ALK-Targeted Therapies in Non-Small Cell Lung Cancer: Comprehensive Insights and Future Directions

<b>Background and Objective:</b> This review comprehensively explores the intricate landscape of anaplastic lymphoma kinase (ALK), focusing specifically on its pivotal role in non-small cell lung cancer (NSCLC). Tracing ALK’s discovery, from its fusion with nucleolar phosphoprotein (NPM)...

Full description

Bibliographic Details
Main Authors: Hannaneh Parvaresh, Ghazaal Roozitalab, Fatemeh Golandam, Payam Behzadi, Parham Jabbarzadeh Kaboli
Format: Article
Language:English
Published: MDPI AG 2024-01-01
Series:Biomedicines
Subjects:
NSCLC
ALK inhibitors
lung cancer
targeted therapy
precision medicine
Online Access:https://www.mdpi.com/2227-9059/12/2/297

Internet

https://www.mdpi.com/2227-9059/12/2/297

Similar Items